Treatment for MRSA
Methicillin-resistant staphylococcus aureus (MRSA) is a strain of staph bacteria that has become resistant to many antibiotics through the years. While doctors can treat typical strains of staph with topical or oral antibiotics, these antibiotic-resistant bacteria are much more difficult to kill. What makes them worse is the fact that MRSA can cause severe infections in some cases, some of which may be life-threatening if left untreated. Depending on whether you are exposed to MRSA in a hospital or long-term care setting or in public, it may be possible to treat the infection with certain types of antibiotics. Unfortunately, hospital-associated MRSA (HA-MRSA) is much more difficult to treat since it is resistant to many more types of antibiotics than community-associated MRSA (CA-MRSA). If you are suffering from any type of MRSA infection, it can help to know some options for treatment for MRSA.
Treatment for MRSA Infection in Hospitals
Because MRSA is so widespread in hospitals and other types of long-term care facilities, treating it with antibiotics can prove quite difficult. Statistics show that, in many cases, the bacteria develop immunities to new antibiotics within weeks of testing them on patients, which can make MRSA infections very difficult to cure in these settings. However, one drug that has been somewhat successful at treating MRSA bacterial infections is vancomycin, an antibiotic that doctors have considered the gold standard for treating staph infections. Unfortunately, when used as single-drug therapy to treat these infections, vancomycin has been largely unsuccessful. Doctors report a 44 percent failure rate in treating bacteremia, a presence of bacteria in the bloodstream, and a 40 percent failure rate in treating lower respiratory-tract infections.
Treatment for MRSA in Communities
Typically, a doctor will treat the community form of MRSA infection by incision and draining of boils or sores. If the infection has gone beyond a simple skin disease, it may be necessary to use antibiotics.
Fortunately, CA-MRSA is often much more treatable than HA-MRSA, simply because certain forms of the bacteria are less resistant to antibiotics. Vancomycin is also useful for treating staph infections in patients suffering from CA-MRSA; however, doctors must often combine it with other drugs for full effectiveness. Unfortunately, there is no oral form of vancomycin, so patients taking the medication must stay connected to an IV at all times. In addition, they must visit a daily infusion center or have home infusion service, and visiting a lab or hospital to receive the drug costs approximately $100 per day, making this impractical for people without health insurance or out of a hospital setting. While there are a few other options for treatment for MRSA in communities, they are extremely expensive (about $1,200 for a ten-day supply) and are therefore not feasible for people without health insurance.
For patients suffering from MRSA, it is necessary to explore some viable options for treatment for MRSA, as this strain of bacteria can create a nasty infection that can be life threatening in some cases. If you are suffering from any type of infection, you should visit a medical professional promptly, as he or she can diagnose your condition and treat it accordingly.